close

茴香(FennelFoeniculum vulgare)

 

繖形科(UmbelliferaeApiaceae)茴香屬(Foeniculum)

學名:Foeniculum vulgare

中文名:茴香、甜茴香、苦茴香

 

DC茴香.jpg

1(A)茴香(Foeniculum vulgare)#1(B)茴香籽#2

 

變種(或亞種?)的茴香籽有不同味道,F. vulgare var. dulce是甜茴香,亞種piperitum是苦茴香,F. vulgare var. vulgare 在文獻紀載中有甜也有苦#1,3

 

【生理活性】

 

精油主要萃取於種子,甜茴香籽精油主成分有反式茴香腦(trans-anethole81.63%-87.85%)#4、葑酮(fenchone)、草嵩腦(estragole)α-水芹烯(α-phellandrene)。精油的雌激素特性源於反式茴香腦,或是相關聚合物雙茴香腦(dianethole)和光茴香腦(photoanethole)#3。茴香的主成分之一,草嵩腦,分子結構和可能致癌物甲基丁香酚(methyl eugenol)相似,多項體外和動物實驗證明有致癌性,歐盟因此原因將草嵩腦添加於非酒精飲料的濃度限制在10 mg/kg#5。除了以上成分,茴香還包含多種酚酸、黃酮類和二苯乙烯類 (stilbene)等酚類物質,在生理活性的表現上,這些成分預期都能有程度不等的貢獻。

 

民俗療法

 

茴香具有解脹氣特性,複方甘草(liquorice)粉常會另外添加茴香,以緩和甘草助瀉產生可能的副作用。茴香水混合小蘇打和糖漿能治療嬰幼兒不明的哭或腸胃問題,國外已有類似產品販售。茴香也應用在催乳上,這可能和它的雌激素特性有關。茴香籽茶也能治療脹氣,印度人相信生吃茴香籽對視力有幫助。茴香籽萃取物在動物實驗顯示,有治療青光眼、高血壓和作為利尿劑的潛在功效。#3

 

抗氧化

 

茴香精油的抗氧化力表現類似維他命E2,6-二丁基羥基甲苯(butylated hydroxytoluene (BHT))等常見抗氧化物#6。實驗證明,茴香籽丁醇和水萃取物能減少油脂的過氧化並消滅自由基,不過整體抗氧化力比槲皮素(黃酮類物質)弱,約僅10%#7。一篇來自埃及的研究表示,當地3種變種有機茴香籽的精油成分明顯有差異,經檢測其中2種所表現出的抗氧化力和2,6-二丁基羥基甲苯相似,大幅優於另1#8

 

抗菌

 

茴香精油能抑制大腸桿菌、金黃色葡萄球菌、李斯特菌、巨桿菌(Bacillus megaterium)和多重抗藥性鮑氏不動桿菌(Acinetobacter baumannii)#3, 9-11。茴香的酒精和水萃取物可抑制曲狀桿菌(Campylobacter jejuni)和幽門螺旋桿菌(Helicobacter pylori)#12

 

精油或是萃取物也可抗真菌,包括白色念珠菌#13-14、核盤菌(Sclerotinia sclerotiorum)#15、黑黴菌(Aspergillum niger)、黃麴黴菌(Aspergillum flavus)、禾穀鐮孢菌(Fusarium graminearum)和串珠鐮孢菌(Fusarium moniliforme)#16

 

抗血栓

 

茴香精油有抗凝血、使血塊崩解(destabilize)的能力。豚鼠血液試驗證明,精油能抑制因化學物質、酵素和膠原蛋白誘發的血液凝集。在大鼠動脈觀察到茴香精油和茴香腦有減緩血管舒張功效。小鼠每日口服茴香精油或茴香腦(30 mg/kg)持續5天,可保護小鼠因靜脈注射膠原蛋白-腎上腺素引起的血栓性癱瘓,保護效果分別達70%83%#17

 

抗發炎

 

誘發發炎前1小時先給予小鼠或大鼠口服200 mg/kg的茴香籽甲醇萃取物,經發炎後3小時,可減少發炎反應60 - 75%。血液中麩胺酸苯醋酸轉氨基酶 (aspartate aminotransferaseAST)的活性升高和細胞損傷發炎有正相關性,作者注射甲醛到大鼠體內誘發關節炎,實驗顯示持續7日口服200 mg/kg茴香籽甲醇萃取物的大鼠,牠們的麩胺酸苯醋酸轉氨基酶活性和對照組相比,顯著較低。#18

 

抗過敏、止痛

 

在化學藥物引起的延遲性第IV型過敏反應研究#18,持續7日口服200 mg/kg茴香籽甲醇萃取物的小鼠能有效抑制耳部腫脹發生,抑制率可到94%。經口服200 mg/kg茴香籽甲醇萃取物的小鼠在疼痛耐受性試驗中,耐受時間能從19.5秒延長至34.3秒。

 

緩解經痛

 

30位年齡在15-24歲有經痛困擾的年輕女性,每人經歷3輪實驗,第一輪無給藥,第二輪口服止痛藥甲芬那酸 (mefenamic acid)(250 mg,每6小時1),第三輪口服2%茴香籽萃取物(25滴,每4小時1),結果參與女性自評認為口服甲芬那酸和茴香期間,都明顯比無給藥時更能減少經痛,其中甲芬那酸在月經第23天表現明顯優於茴香,其它天則無顯著差異#19

 

護肝

 

茴香籽精油在大鼠實驗顯示有護肝功效#20,每周3次持續7周腹腔注射0.3 ml/kg精油的大鼠除了顯著減少血液中與肝指數相關的酵素活性,從病理切片也觀察到茴香籽精油能阻止發展成慢性肝炎。

 

降血糖、抗糖尿病

 

口服30 mg/kg bw茴香精油的糖尿病大鼠,經21天實驗後,可有效降低血糖從162.5 ± 3.19 mg/dl81.97 ± 1.97 mg/dl,且能提升抗氧化酵素活性,反轉原本因氧化壓力造成的腎和胰臟損傷,恢復健康#21

 

減少嬰幼兒不明哭泣

 

每日4次飯前給予嬰幼兒茴香油,每日劑量不超過12 mg/kg,結果在1252-12周歲嬰兒參與的試驗顯示,實驗組有65%能有效改善症狀,對照組僅23.7%#22-23

 

抗壓

 

短期壓力導致腎上腺素增加,腎上腺素經代謝會產生香草扁桃酸(vanillylmandelic acid)代謝物。長期壓力則會分泌可體松(cortisol),補充維他命C能抑制可體松達到減壓效果#24。根據研究,施予壓力前就口服不同劑量茴香籽水萃取物的大鼠,相較於對照組,在施壓後24小時其尿液中香草扁桃酸濃度較低、維他命C濃度更高,顯著表現抗壓反應,且口服劑量越高,抗壓效果越明顯#25

 

可能風險

 

大鼠實驗顯示,草嵩腦濃度和產生突變性代謝物的機率成正比#26。雖然多項體外和動物實驗指出#27-31草嵩腦具有致癌性,然而致癌性可能因組織、性別和物種而有差異,就近期研究結果,沒有直接證據證明草嵩腦會導致人類罹癌#3,不過歐盟依然顧慮其毒性而管制在食品的添加量#32

 

雖然沒有任何研究探討,但著有Clinical Aromatherapy的作者Jane Buckle會建議癲癇患者避開迷迭香、茴香、牛膝草松樟酮 (Hyssopus officinalis CT pinocamphone)和胡椒薄荷精油。懷孕和癌症患者也不適合使用茴香精油,因雌激素會促進有些腫瘤的生長。#22

 

芳療功效】

 

嗅聞茴香和薑混合精油能改善暈船()的不適感,減少噁心、嘔吐。每日3次塗擦3%茴香精油在手腕處(視情況可增加次數)持續2周,實驗發現能降低食慾,有助減重,實驗組最終平均減3.51磅,對照組平均2.81磅。#22

 

【料理應用】

 

甜茴香籽帶有甜味,味道似八角(Illicium verum)或大茴香(Pimpinella anisum),時常用在魚肉、肉類、冰淇淋、酒精飲料、香草茶、烘焙或綜合香料#33。茴香的莖脆口,它的塊根可燉、燜、炒或烤料理,也可以生吃。地中海料理喜歡使用球莖和嫩葉,可生吃或烹調應用在沙拉、附餐、義大利麵或蔬食料理。印度次大陸和中東地區有添加茴香籽調味的料理文化,茴香也是印度少數民族的重要香料。#3

 

參考文獻:

(1)Huang, Baokang, He, Weiping. A review of chemistry and bioactivities of a medicinal spice: foeniculum vulgare. J. Med. Plants Res. 2011;5:3595–3600.

(2)Shamkant B. Badgujar, Vainav V. Patel, Atmaram H. Bandivdekar. Foeniculum vulgareMill: A Review of Its Botany, Phytochemistry, Pharmacology, Contemporary Application, and Toxicology. BioMed Research International 2014; 2014: 1

(3)Rather MA, Dar BA, Sofi SN, Bhat BA, Qurishi MA. Foeniculum vulgare: A comprehensive review of its traditional use, phytochemistry, pharmacology, and safety. Arab J Chem 2012. doi: 10.1016/j. arabjc.2012.04.011

(4)Telci, I., Demirtas, I., Sachin, A., 2009. Variation in plant properties and essential oil composition of sweet fennel (Foeniculum vulgare Mill.) fruit during stages of maturity. Ind. Crops Prod. 30, 126–130.

(5)Zeller, A., Rychlik, M., 2006. Character impact odorants of fennel fruits and fennel tea. J. Agric. Food Chem. 54, 3686–3692.

(6)Ruberto, G., Baratta, M.T., Deans, S.G., Dorman, H.J.D., 2000. Antioxidant and antimicrobial activity of Foeniculum vulgare and Crithmum maritimum essential oils. Planta Med. 66, 687–693.

(7)Marino, S.D., Gala, F., Borbone, N., Zollo, F., Vitalini, S., Visioli, F., Iorizzi, M., 2007. Phenolic glycosides from Foeniculum vulgare fruit and evaluation of antioxidative activity. Phytochemistry 68, 1805–1812.

(8)Shahat, A.A., Ibrahim, A.Y., Hendawy, S.F., Omer, E.A., Hammouda, F.M., Rahman, F.H.A., Saleh, M.A., 2011. Chemical composition, antimicrobial and antioxidant activities of essential oils from organically cultivated fennel cultivars. Molecules 16, 1366–1377.

(9)Mohsenzadeh, M., 2007. Evaluation of antibacterial activity of selected Iranian essential oils against Staphylococcus aureus and Escherichia coli in nutrient broth medium. Pak. J. Biol. Sci. 10, 3693–3697.

(10)Dadalioglu, I., Evrendilek, G.A., 2004. Chemical compositions and antibacterial effects of essential oils of Turkish oregano (Origanum minutiflorum), bay laurel (Laurus nobilis), Spanish lavender (Lavandula stoechas L.), and fennel (Foeniculum vulgare) on common foodborne pathogens. J. Agric. Food Chem. 52, 8255–8260.

(11)Cantore, P.L., Iacobelli, N.S., Marco, A.D., Capasso, F., Senatore, F., 2004. Antibacterial activity of Coriandrum sativum L. and Foeniculum vulgare Miller Var. vulgare (Miller). Essential oils. J. Agric. Food Chem. 52, 7862–7866.

(12)Mahady, G.B., Pendland, S.L., Stoia, A., Hamill, F.A., Fabricant, D., Dietz, B.M., Chadwick, L.R., 2005. In-vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastro-intestinal disorders. Phytother. Res. 19, 988–999.

(13)Pai, M.B., Prashant, G.M., Murlikrishna, K.S., Shivakumar, K.M., Chandu, G.N., 2010. Antifungal efficacy of Punica granatum, Acacia nilotica, Cuminum cyminum and Foeniculum vulgare on Candida albicans: an in vitro study. Indian J. Dental Res. 21 (3),334–336.

(14)Abed, K.F., 2007. Antimicrobial activity of essential oils of some medicinal plants from Saudi Arabia. Saudi J. Biol. Sci. 14, 53–60.

(15)Soylu, S., Yigitbas, H., Soylu, E.M., Kurt, S., 2007. Antifungal effects of essential oils from oregano and fennel on Sclerotinia sclerotiorum. J. Appl. Microbiol. 103, 1021–1030.

(16)Singh, G., Maurya, S., de Lampasona, M.P., Catalan, C., 2006. Chemical constituents, antifungal and antioxidative potential of Foeniculum vulgare volatile oil and its acetone extract. Food Control 17, 745–752.

(17)Tognolini, M., Ballabeni, V., Bertoni, S., Bruni, R., Impicciatore, M., Barocelli, E., 2007. Protective effect of Foeniculum vulgare essential oil and anethole in an experimental model of thrombosis. Pharmacol. Res. 56, 254–260.

(18)Choi, E.M., Hwang, J.K., 2004. Anti-inflammatory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare. Fitoterapia 75 (2004), 557–565.

(19)Namavar Jahromi B, Tartifizadeh A, Khabnadideh S. Comparison of fennel and mefenamic acid for the treatment of primary dysmenorrhea. Int J Gynaecol Obstet 2003; 80:153-7.

(20)Özbek, H., Ugras, S., Bayram, I., Uygan, I., Erdogan, E., Öztürk, A., Huyut, Z. (2004) Hepatoprotective effect of Foeniculum vulgare essential oil: A carbon tetrachloride induced liver fibrosis model in rats. Scandinavian Journal of Laboratory Animal Science, 31(1); 9-17

(21)El-Soud, N.A., El-Laithy, N., El-Saeed, G., Wahby, M.S., Khalil, M., Morsy, F., Shaffie, N., 2011. Antidiabetic activities of Foeniculum vulgare Mill. Essential oil in Streptozotocin induced diabetic rats. Macedonian J. Med. Sci. 173, 1857–5773.

(22)Jane Buckle, PhD, RN, Clinical Aromatherapy: Essential Oils in Healthcare (Third Edition. United Kingdom: Churchill Livingstone Elsevier, 2015)

(23)Alexandrovich I, Rakovitskaya O, Kolmo E, Sidorova T, Shushunov S. The effect of fennel (Foeniculum vulgare) seed oil emulsion in infantile colic: a randomized, placebo-controlled study. Altern Ther Health Med. 2003; 9(4):58-61.

(24)Liakakos D, Doulas NL, Ikkos D, et al. Inhibitory effect of ascorbic acid (vitamin C) on cortisol secretion following adrenal stimulation in children. Clin Chim Actab. 1975;65:251-255.

(25)S. Koppula and H. Kumar, “Foeniculum vulgare Mill (Umbelliferae) attenuates stress and improves memory in wister rats,” Tropical Journal of Pharmaceutical Research, vol. 12, no. 4, pp. 553–558, 2013.

(26)Punt, A., Freidig, A.P., Delatour, T., Scholz, G., Boersma, M.G., Schilter, B., van Bladeren, P.J., Rietjens, I.M., 2008. A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat. Toxicol. Appl. Pharmacol. 231, 248–259.

(27)Swanson, A.B., Chambliss, D.D., Blomquist, J.C., Miller, E.C., Miller, J.A., 1979. The mutagenicities of safrole, estragole, eugenol, transanethole, and some of their known or possible metabolites for Salmonella typhimurium mutants. Mutat. Res. 60, 143–153.

(28)Swanson, A.B., Miller, E.C., Miller, J.A., 1981. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes. Biochim.Biophys. Acta 673, 504–516.

(29)Miller, J.A., Miller, E.C., 1983. The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragole. Brazilian J. Cancer 48, 1–15.

(30)Miller, E.C., Swanson, A.B., Phillips, D.H., Fletcher, T.L., Liem, A., Miller, J.A., 1983. Structure–activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenyl-benzene derivatives related to safrole and estragole. Cancer Res. 43, 1124–1134.

(31)Paini, A., Punt, A., Viton, F., Scholz, G., Delatour, T., Marin- Kuan, M., Schilter, B., van Bladeren, P.J., Rietjens, I.M., 2010. A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes. Toxicol. Appl. Pharmacol. 245, 57–66.

(32)No. 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and certain food ingredients with flavouring properties for use in and on foods and amending Council. Regulation (EEC) No. 1601/91, Regulations (EC) No. 2232/96 and (EC) No. 110/2008 and Directive 2000/13/EC. OJL, 354 (2008), pp. 34-50

(33)Diaaz-Maroto, M.C., Hidalgo, I.J.D., Saa nchez-Palomo, E., Pea¨ rez-Coello, M.S., 2005. Volatile components and key odorants of fennel (Foeniculum vulgare Mill.) and thyme (Thymus vulgaris L.) Oil extracts obtained by simultaneous distillation–extraction and supercritical fluid extraction. J. Agric. Food Chem. 53, 5385–5389.

arrow
arrow
    創作者介紹
    創作者 cofactor412 的頭像
    cofactor412

    pancakes的部落格

    cofactor412 發表在 痞客邦 留言(0) 人氣()